Should atypical lymphocytes and plasma cells in well patients with psoriasis on cyclosporin cause concern?
Edwards
B D
BD
Ballardie
F W
FW
Morris
D J
DJ
O'Driscoll
J B
JB
Chalmers
R J
RJ
D016572:Cyclosporine / Q000009:adverse effects / Q000627:therapeutic use*; D003587:Cytomegalovirus / Q000187:drug effects; D004854:Herpesvirus 4, Human / Q000187:drug effects; D006801:Humans; D008214:Lymphocytes / Q000187:drug effects* / Q000473:pathology*; D008223:Lymphoma / Q000139:chemically induced; D010950:Plasma Cells / Q000187:drug effects* / Q000473:pathology*; D011565:Psoriasis / Q000188:drug therapy*; D012307:Risk Factors; D014775:Virus Activation / Q000187:drug effects
D016572:Cyclosporine